Current CDC Travel Health Notices list no Level 4 designations as of late May 2026, reflecting the absence of any outbreak meeting the agency’s threshold of extreme risk with no available precautions. Ongoing surveillance of Ebola in the Democratic Republic of the Congo, Uganda, and South Sudan has prompted enhanced entry screening and temporary restrictions rather than full “Avoid All Travel” notices, while other pathogens such as influenza, mpox, dengue, and polio remain at Level 2 or below under WHO and CDC monitoring. Model projections and case trends through mid-2026 show no exponential growth or novel high-fatality strains that historically trigger Level 4 status. Absent a rapid escalation before December 31, trader consensus at 76.5% for “No” aligns with these moderate transmission patterns and the strict resolution criteria.
Polymarket ডেটা রেফারেন্স করে পরীক্ষামূলক AI-জেনারেটেড সারাংশ। এটি ট্রেডিং পরামর্শ নয় এবং এই মার্কেট কীভাবে রেজলভ হয় তাতে কোনো ভূমিকা রাখে না। · আপডেটেডCDC issues Level 4 warning by December 31?
CDC issues Level 4 warning by December 31?
$71,809 Vol.
$71,809 Vol.
Dec 31, 2026
$71,809 Vol.
$71,809 Vol.
Dec 31, 2026
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Current CDC Travel Health Notices list no Level 4 designations as of late May 2026, reflecting the absence of any outbreak meeting the agency’s threshold of extreme risk with no available precautions. Ongoing surveillance of Ebola in the Democratic Republic of the Congo, Uganda, and South Sudan has prompted enhanced entry screening and temporary restrictions rather than full “Avoid All Travel” notices, while other pathogens such as influenza, mpox, dengue, and polio remain at Level 2 or below under WHO and CDC monitoring. Model projections and case trends through mid-2026 show no exponential growth or novel high-fatality strains that historically trigger Level 4 status. Absent a rapid escalation before December 31, trader consensus at 76.5% for “No” aligns with these moderate transmission patterns and the strict resolution criteria.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
মার্কেট ওপেন হয়েছে: Jan 19, 2026, 3:15 PM ET
ভলিউম
$71,809শেষ তারিখ
Dec 31, 2026মার্কেট ওপেন হয়েছে
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Current CDC Travel Health Notices list no Level 4 designations as of late May 2026, reflecting the absence of any outbreak meeting the agency’s threshold of extreme risk with no available precautions. Ongoing surveillance of Ebola in the Democratic Republic of the Congo, Uganda, and South Sudan has prompted enhanced entry screening and temporary restrictions rather than full “Avoid All Travel” notices, while other pathogens such as influenza, mpox, dengue, and polio remain at Level 2 or below under WHO and CDC monitoring. Model projections and case trends through mid-2026 show no exponential growth or novel high-fatality strains that historically trigger Level 4 status. Absent a rapid escalation before December 31, trader consensus at 76.5% for “No” aligns with these moderate transmission patterns and the strict resolution criteria.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
ভলিউম
$71,809শেষ তারিখ
Dec 31, 2026মার্কেট ওপেন হয়েছে
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Current CDC Travel Health Notices list no Level 4 designations as of late May 2026, reflecting the absence of any outbreak meeting the agency’s threshold of extreme risk with no available precautions. Ongoing surveillance of Ebola in the Democratic Republic of the Congo, Uganda, and South Sudan has prompted enhanced entry screening and temporary restrictions rather than full “Avoid All Travel” notices, while other pathogens such as influenza, mpox, dengue, and polio remain at Level 2 or below under WHO and CDC monitoring. Model projections and case trends through mid-2026 show no exponential growth or novel high-fatality strains that historically trigger Level 4 status. Absent a rapid escalation before December 31, trader consensus at 76.5% for “No” aligns with these moderate transmission patterns and the strict resolution criteria.
Polymarket ডেটা রেফারেন্স করে পরীক্ষামূলক AI-জেনারেটেড সারাংশ। এটি ট্রেডিং পরামর্শ নয় এবং এই মার্কেট কীভাবে রেজলভ হয় তাতে কোনো ভূমিকা রাখে না। · আপডেটেড
বাহ্যিক লিংক থেকে সাবধান।
বাহ্যিক লিংক থেকে সাবধান।
সচরাচর জিজ্ঞাসা